CCL22 and coronary artery disorder: The expressions of PTPN21 and CALB1 were significantly elevated, while the expressions of C1orf105, CCL22, CRYGB, FRK, GAP43, and REG1P were significantly decreased in the CAD samples of the merged dataset (Supplementary Figure S2).